The Cannabist Company

The Cannabist Company es una empresa que cotiza bajo el símbolo de cotización CCHW (US).

Ver el organigrama con sus 23 ejecutivos principales

Biografías más buscadas en The Cannabist Company

• David Hart, Chief Executive Officer
• Nicholas Vita, Director
• Jonathan May, Lead Director

Crear su alerta
para seguir los movimientos de los ejecutivos en The Cannabist Company.

The Cannabist Company tiene 1.863 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Johnson & Johnson (Estados Unidos).

Popular M&A news in Farmacia

• AstraZeneca has announced the acquisition of Fusion Pharma  (publicado el 23 de marzo de 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (publicado el 19 de marzo de 2024).
• Frontier Medicines acaba de anunciar una recaudación de fondos de 80 millones de dólares. (publicado el 27 de febrero de 2024).

Otros contactos sugeridos en el sector Farmacia

• Jean-Frédéric Paulsen - Executive Chairman of the Board en Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director en Dirk Rossmann
• Thierry Abribat - Chief Executive Officer en Amolyt Pharma

Saber más sobre el sector Farmacia >

Últimos comunicados de prensa de The Cannabist Company

• Press Releases | The Cannabist Company
• The Cannabist Company Announces Launch of its Award-Winning Triple Seven Brand in New York and Florida | The Cannabist Company
• The Cannabist Company and Revelry Expand Partnership to Four New East Coast Markets | The Cannabist Company
• Press Releases | The Cannabist Company
• The Cannabist Company Announces New Multi-State Retail, Manufacturing and Wholesale Partnership with Women-Led Brand, Flower by Edie Parker | The Cannabist Company
• The Cannabist Company to Report First Quarter 2024 Results on May 9, 2024 | The Cannabist Company
• The Cannabist Company Reports Fourth Quarter and Full Year 2023 Results | The Cannabist Company
• The Cannabist Company Announces Intent to Complete US$25.75 Million Private Placement Offering of 9% Senior Secured Convertible Debentures Due 2027 | The Cannabist Company
• The Cannabist Company Announces Closing of US$25.75 Million Private Placement Offering of 9% Senior Secured Convertible Debentures Due 2027 | The Cannabist Company
• The Cannabist Company Highlights Product Innovation with Launch of Unique Fast-Acting and Longer-Lasting Layered Edibles | The Cannabist Company
• View more press releases Close

Redes sociales sobre The Cannabist Company

• The Cannabist Company en Wikipedia, Google News y Yahoo Finance
• The Cannabist Company en LinkedIn, Twitter y YouTube

Contactar a través de e-mail con sus ejecutivos David Hart

Llame a The Cannabist Company al +1 212...

Ver el organigrama

Register to receive your alert

Señalar un error